Octagon Capital Advisors LP Connect Biopharma Holdings LTD Transaction History

Octagon Capital Advisors LP

  • $414 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.56 - $3.25 $156,755 - $909,743
-279,921 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$4.26 - $23.33 $196,905 - $1.08 Million
-46,222 Reduced 14.17%
279,921 $1.44 Million
Q3 2021

Nov 15, 2021
SELL
$18.12 - $28.5 $857,963 - $1.35 Million
-47,349 Reduced 12.68%
326,143 $7.8 Million
Q1 2021

May 17, 2021
BUY
$15.9 - $18.61 $5.94 Million - $6.95 Million
373,492 New
373,492 $6.91 Million

Others Institutions Holding CNTB

# of Institutions
12
Shares Held
3.05M
Call Options Held
0
Put Options Held
0
View Full List

About Connect Biopharma Holdings Ltd

CNTB Quotes by TradingView
  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $52.3M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email